ALBERT

Keywords: R5-920 ; RM1-950 ; tissue engineering ; cyclodextrin ; permeability ; poly (vinylpyrrolidone-co-vinyl acetate) ; crystalline ; antibacterial ; drug delivery ; homogenization ; capsaicin ; combination therapy ; high-shear mixing ; cyclodextrin-inclusion complexes ; amorphous ; high-speed electrospinning ; PMVE/MA ; aqueous solubility enhancement ; sieve analysis ; Raman mapping ; Eudragit ; nanofibers ; psoriasis ; PCL ; essential oils ; parameters ; antibiotics ; xanthan gum ; carvedilol ; amorphous composite ; coaxial electrospinning ; insoluble drug ; NIR-triggered drug release ; fast dissolution ; electrospinning ; oral drug delivery ; electrospun nanofibers ; poly-cyclodextrin ; TRPV1 ; gallic acid ; solid dispersion ; photothermal therapy ; drug release ; applications ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Adequate hydration ; Beverages consumption ; Water and energy intake ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; gluten-related disorders；celiac disease；gluten intolerance ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; chitosan ; intestinal epithelial cells ; ocular delivery ; amphiphilic polymers ; cornea ; tight junction modulator ; cyclodextrin ; permeability ; gemini surfactant ; transferrin ; compound 48/80 ; epithelial permeability ; cervicovaginal tumors ; nanoparticles ; confocal laser scanning microscopy ; safety ; formulation ; salcaprozate sodium ; intestinal absorption ; FITC-dextran ; curcumin ; block copolymers ; nasal vaccination ; whole leaf ; brush border ; ocular drug delivery ; vaccine adjuvant ; nanoparticle ; nasal delivery ; efflux ; permeation enhancers ; absorption enhancers ; nose to brain delivery ; small intestine ; epithelium ; CNS disorders ; absorption modifying excipients ; insulin ; absorption enhancer ; gel ; intestinal delivery ; thermogel system ; Caco-2 ; biocompatibility studies ; absorption enhancement ; man ; PN159 ; poorly absorbed drug ; tryptophan ; tight junction ; oral macromolecule delivery ; penetration enhancer ; intestinal permeation enhancers ; nanocrystals ; simvastatin ; nanomedicine ; enterocyte ; N-dodecyl-?-D-maltoside (DDM) ; cell-penetrating peptide ; quaternization ; KLAL ; nasal ; nasal permeability ; transmucosal drug delivery ; Caco-2 cells ; mast cell activator ; penetration enhancers ; drug delivery ; nose-to-brain ; bioenhancer ; polymeric micelles ; mucoadhesion ; cell-penetrating peptide (CPP) ; simulated intestinal fluid ; vaginal delivery ; nasal formulation ; pharmacokinetic interaction ; sodium caprate ; clinical trial ; transmucosal permeation ; drug absorption enhancer ; sugar-based surfactants ; nanocapsules ; imatinib ; teriparatide ; osteoporosis ; hydrophobization ; F-actin ; combined microsphere ; transepithelial electrical resistance ; oral delivery ; ocular conditions ; metabolism ; antimicrobial peptide ; permeation enhancer ; drug administration ; antiepileptic drug ; amino acid ; in vivo studies ; sodium cholate (NaC) ; epithelial transport ; preclinical ; nose to brain transport ; pharmacokinetics ; chitosan derivatives ; ophthalmology ; tight junctions ; sheep ; cationic functionalization ; GLP-1 ; pulmonary ; and liposome ; cytochrome P450 ; claudin ; P-glycoprotein ; in situ hydrogel ; mucoadhesiveness ; PTH 1-34 ; Aloe vera ; oral peptides ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; toxicology ; marine toxins ; drug discovery ; marine natural compounds and their derivatives ; xenograft models ; drug combination ; cancer ; drug resistance ; cancer-preventive activity ; molecular effects ; molecular targets ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; fatigue syndrome ; n/a ; work rehabilitation ; tryptophan metabolism ; substrate inhibition ; myalgic encephalomyelitis ; 3-dioxygenase ; ME (Myalgic Encephalomyelitis) ; assessment ; myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) ; muscles ; hypoacetylation ; circadian rhythm ; immune system ; chronic ; CFS (Chronic Fatigue Syndrome) ; energy metabolism ; ME/CFS ; immunological ; cytokine ; bistability ; diagnosis ; biomarker ; symptoms ; kynurenine pathway ; inflammation and immunity ; metabolism ; neuro-inflammation ; pathology ; signaling ; exercise ; Epstein Barr virus ; methylhistidine ; hypothalamic–pituitary–adrenal axis ; potential biomarkers ; critical point ; inflammation ; histone deacetylation ; participatory research ; neurology ; neuroimmune ; activin ; mitochondria ; patient-driven questionnaire ; medical retirement ; machine learning ; prognosis ; gut microbiota ; post-exertional malaise ; chronic fatigue syndrome ; mathematical model ; reference intervals ; diagnostic biomarker ; indoleamine-2 ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; n/a ; biomaterial ; redifferentiation ; regenerative medicine ; skeletal muscle regeneration ; furcation defects ; Platelet-Rich Plasma (PRP) ; PRP ; fracture ; fibrin sealant ; periodontal surgery ; bone regeneration ; serum derived from plasma rich in growth factors (s-PRGF) ; cartilage repair ; myofibroblasts ; autologous platelet concentrates ; burns ; satellite cells ; articular cartilage ; stem cell niche ; wound healing ; quantification ; growth factors ; biologics ; platelet rich plasma ; meniscus ; adipose tissue ; Carprofen ; platelet-rich fibrin ; platelets ; hyperacute serum ; bone defects ; serum eye drops ; corneal epithelial defect ; fibrosis ; dog ; myoblasts ; differentiation ; chronic meniscal lesion ; horizontal meniscal tear ; PRGF ; collagen hydrogels ; periodontal defects ; bone grafting material ; composition ; cell therapy ; bone healing ; tissue healing ; trephination ; plasma rich plasma (PRP) ; bone repair ; plasma rich in growth factors ; knee arthrosis ; meniscus tear ; cornea regeneration ; wrist osteoarthritis ; periosteal sheet ; Platelet-Poor Plasma (PPP) ; platelet-rich plasma ; microfat ; bone grafting ; hyaluronic acid (NaHA) ; periodontal regeneration ; meniscus repair ; photobiomodulation therapy ; growth ; myogenesis ; blood derived products ; low-level laser therapy ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC620-627 ; gluten ; n/a ; mental health ; 33-mer ; gut motility ; gluten re-introduction ; teenagers ; gastric emptying ; islet of Langerhans ; children ; high-fat diet-induced obesity ; affective disorders ; FODMAP intake ; Brazilian CD-QoL ; DQ2.5-glia-?3 epitopes ; place of residence ; zinc ; glutenin ; quality of life (QoL) ; mood disorders ; magnesium ; dietary adherence ; coeliac disease ; food habit ; villous atrophy ; pepsin ; peptides derived from gluten in faeces and urine ; beta cell ; body mass index (BMI) ; oral food challenge ; gliadin ; ?-gliadin ; non-celiac gluten sensitivity ; celiac disease ; wheat ; outcome ; DQ2.5-glia-?1 ; DQ2.5-glia-?2 ; gut microbiota ; type 2 diabetes ; major depressive disorder ; micronutrient ; beta-cell stress ; non-coeliac gluten sensitivity ; screening ; gluten free diet ; gluten-related disorders ; threshold ; diary recommended intake ; wheat species ; non-coeliac wheat sensitivity ; body composition ; serology ; educational level ; mineral ; disease duration ; gastrointestinal symptoms ; gluten-free diet ; NOD mouse ; diagnosis ; osteoporosis ; nutrition ; cholecyst ; wheat allergy ; celiac disease (CD) ; quality of life ; microbiota ; questionnaire ; nutritionists ; structured questionnaires ; Pseudomonas ; intestinal permeability ; Celiac Disease ; economic status ; effectiveness ; type 1 diabetes ; cost ; calcium ; irritable bowel syndrome ; adherence ; non celiac gluten sensitivity ; deficiency ; gluten sensitivity ; iron ; low FODMAP diet ; depression ; clinic ; duodenal biopsies ; fortification ; mucosal recovery ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; TA1-2040 ; RM1-950 ; fiber optic sensor ; computational optical sensing and imaging ; imaging spectroscopy ; spectral imaging ; optical coherent tomography ; optical feedback interferometry ; optical tomography ; Raman sensing and imaging ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC581-607 ; immunonutrition ; supplementation ; superoxide dismutase (SOD) ; fermented milk ; selenocysteine ; dendritic cells ; lipoxygenase (LOX) ; chronic inflammatory conditions ; formulation ; immune system ; cytokines ; skeletal muscle ; zinc ; non-digestible carbohydrates ; Toll-like receptor ; carbohydrates ; fiber ; lymphocytes ; antibody ; infants ; liver ; macrophage ; inflammatory process ; probiotic ; plant ; older people ; gut barrier ; infection ; amino acids ; gut ; T helper 1 (Th1) ; immunity ; T cells ; bioactive peptide ; inhibitor of kappa kinase (IKK) ; inflammation ; adhesion molecules ; leukocytes ; human milk oligosaccharides ; vitamin D ; food structure ; vitamin E ; mitogen-activated protein Kinase (MAPK) ; gut microbiota ; weaning ; homeostasis ; intestinal immune system ; extra-cellular signal regulated kinases (ERK) ; cyclooxygenase (COX) ; oxidative stress ; life course ; polyphenols ; oligosaccharides ; micronutrients ; Th17 ; obesity ; tolerance ; arachidonic acid ; growth factors ; anti-inflammation ; age-related immunity ; prebiotic ; biomarker ; microbiome ; functional foods ; immunosenescence ; nutrition ; molecular mechanisms ; metabolism ; macronutrients ; toll-like receptor 4 ; sepsis ; nutrition guidelines ; microbiota ; immunomodulation ; inflammatory markers ; elderly ; Th1/Th17 response ; adults ; reactive oxygen species (ROS) ; anorexia nervosa ; macrophages ; autoimmune diseases ; fatty acids ; T cell ; Treg ; breast milk ; nitric oxide synthase (NOS) ; chemokines ; anti-tumorigenic ; metabolites ; deficiency ; protein hydrolysate ; nuclear factor kappa-light-chain-enhancer of activated B cells (NF-?B) ; cancer ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; antibacterial activity ; piroxicam ; n/a ; tissue engineering ; biotechnology ; polydextrose ; solvent casting ; antibacterial ; drug delivery ; diabetic ; pectin ; nanotechnology ; nanocomposite ; hydroxypropyl methyl cellulose ; poorly water-soluble drug ; artificial red blood cells ; oral dosage form ; Lactobacillus ; scanning electron microscopy ; wound healing ; UV imaging ; wetting ; biocompatibility ; scale-up ; polylactide-co-polycaprolactone ; nanofibers ; growth factor ; drug release kinetics ; hydrogel ; differential scanning calorimetry ; bacterial bioreporters ; physical solid-state properties ; PCL ; coaxial spinning ; drug delivery system ; haemanthamine ; probiotics ; amphiphilic nanofibers ; wound dressings ; grinding ; scanning white light interferometry ; biopharmaceuticals ; clove essential oil ; viability ; plant-origin alkaloid ; oligochitosan ; local delivery ; electrospinning ; Lactococcus ; self-assembled liposomes ; microcapsules ; microfibers ; nanofiber ; in situ drug release ; biomedical ; core-sheath nanofibers ; processability ; polymeric carrier ; aceclofenac ; drying ; gentamicin sulfate ; traditional electrospinning ; electrospinning and electrospray ; fourier transform infrared spectroscopy ; drug release ; gelatin ; ultrasound-enhanced electrospinning ; 3D printing ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; screening ; MoCA ; neurodegeneration ; accuracy ; frontotemporal dementia ; cognitive assessment ; Free-Cog ; molecular imaging ; Alzheimer’s ; standardised mini-mental state examination ; decision tree ; differential diagnosis depression vs. MCI/dementia ; computerized cognitive assessment ; quantification ; Alzheimer’s disease ; functional cognitive disorder ; diagnosis ; Triple Test ; diagnostic imaging ; neurocognitive disorder ; feasibility ; TYM-MCI ; amyloid ; cerebrospinal fluid ; dementia ; precision medicine ; Mini-Addenbrooke’s Cognitive Examination ; memory ; depression in old age ; quick mild cognitive impairment screen ; cognition ; nuclear medicine ; TYM ; Rapid Cognitive Screen ; 18F-FDG ; functional neurological disorder cognition ; stroke ; sensitivity and specificity ; Codex ; mortality ; mild cognitive impairment ; cognitive screening instruments ; cognitive impairment ; aging ; SKT (Syndrom-Kurztest) ; PET ; executive function ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; spinal cord injury ; neuroinflammation ; cell therapy ; transcriptomics ; cytokines ; hydrogels ; p38. ; neuronal regeneration ; extracellular matrix ; epidural adhesions ; neuroplasticity ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RJ1-570 ; cognitive behavioral therapy ; pain rehabilitation ; n/a ; education ; pediatric integrative medicine ; musical therapy ; mind-body ; non-pharmacological therapy ; guided imagery ; complementary ; infant ; pediatric ; multidisciplinary pain management strategies ; integrative medicine ; qualitative ; advocacy ; clinic model ; massage ; obesity ; Kneipp ; multidisciplinary ; adolescents ; mindfulness ; sucrose ; program development ; vision ; complementary therapies ; residents ; art therapy ; pastoral care ; academic medicine ; kindergarten ; yoga ; assessment of withdrawal ; clinical practice ; pediatric integrative nursing ; eHealth ; mindful eating ; opioid reduction therapy ; burnout ; resilience ; pediatric blood and marrow transplant ; preventive lifestyle behaviors ; biofeedback ; pain ; migraine ; Integrative therapies ; creative arts therapy ; weaning of opioids ; implementation ; yoga therapy ; mindfulness-based stress reduction ; withdrawal ; music therapy ; hypnosis ; acupuncture ; premature ; chronic illness ; meditation ; pediatrics ; skin-to-skin contact ; opioid therapy ; self-regulation ; headache ; PIMR ; breastfeeding ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; alginate ; chitosan ; gold nanoparticles ; biochemical mechanism ; cancer imaging ; lignin ; thioredoxin reductase ; antimiR ; nanoparticles ; surface enhanced Raman scattering ; biomedical applications ; protein ; multidrug resistant (MDR) microorganisms ; nano-bio interaction ; curcumin ; autophagy ; MIC ; nanoparticle ; biocompatible ; gene delivery ; self-assembly ; glioblastoma ; dual functional imaging nanoprobe ; SERS ; antibiotics ; biogenic nanoparticles ; Hg2+ ions detection ; antimicrobial ; histamine ; layer-by-layer ; dihydroartemisinin ; computational electromagnetism ; photolysis ; Ag-film ; chitosan nanoparticles ; UiO-66 ; plasma liquid Interactions ; anticancer ; MBC ; nanophotonics ; targeted nanoparticles ; near-infrared ; hybrid Fe-Si nanoparticles ; FTIR ; thermoplastic polymer ; synergism ; prognosis ; medical devices ; silver nanoparticles ; glioma ; plasma ; iron oxide superparamagnetic nanoparticles ; oxidative stress ; mycosynthesis ; membrane integrity ; drug delivery ; nanocomposites ; finite element method ; cell labeling ; in vivo application ; non-thermal plasma ; nanocellulose ; biocompatibility ; liposomes ; nanocarriers ; upconversion nanoparticles ; Candida glabrata ; nanomaterials ; middle ear prosthesis ; short-wave infrared ; cytoreduction surgery ; fibril ; nanostars ; fluorescent nanoparticle ; density functional theory calculations ; cross-link ; mitoxantrone ; heat ; SERS sensor ; Caco2 cells ; apoptosis ; surface-enhanced Raman spectroscopy (SERS) ; MFC ; magnetic nanoparticles ; antibiotic resistance ; laser pyrolysis ; cytotoxicity ; core-shell nanoparticles ; enzyme ; extracellular ; nanomaterial synthesis ; cancer cell targeting ; nanodiamond ; breast cancer ; metal-enhanced fluorescence (MEF) ; PEG ; radiation ; trans-resveratrol derivative ; radiosensitization ; cancer ; surface-enhanced Raman scattering (SERS) ; TEM ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; n/a ; FOLFIRINOX ; immunofluorescence imaging ; AR-V7 ; circulating tumour cells ; chemoradioresistance ; CTC-based treatment decisions ; rVAR2 ; immunophenotyping ; immune system ; CellSearch® ; flow cytometry ; clinical trials ; circulating tumor DNA ; synaptophysin ; stem cells ; colorectal cancer ; melanoma ; CTC biology ; platelets ; AR ; CTC capture technology ; castration resistant prostate cancer (CRPC) ; PD-L1 expression ; rovalpituzumab tesirine ; HMB-45 ; thymidylate synthase ; ctDNA ; tumor cell dissemination ; solid cancers ; metastasis ; locally advanced rectal cancer ; miRNA ; epithelial-to-mesenchymal transition (EMT) ; NSCLC ; tumor biomarkers ; tumor stem cells ; circulating tumor cells ; major histocompatibility complex class I (MHCI) ; bone marrow ; heterogeneity ; cerebrospinal liquid biopsy ; fish ; glioma ; in vivo flow cytometry ; colorectal surgery ; CellSearch ; single-cell analysis ; disseminated tumor cells ; EasyCount slides ; microsatellite instability ; circulating plasma cells ; circulating leukemia cells ; ARV7 ; SLUG ; androgen receptor ; metastatic colorectal cancer ; leukocyte-derived extracellular vesicles ; prostate cancer (PCa) ; neutrophils ; liquid biopsy ; enzalutamide ; CD133 ; enrichment and detection technologies ; biomarkers ; immune checkpoint inhibitors ; biomarker ; RAD23B ; microbiome ; integrin B1 ; ACCEPT ; emboli ; small-cell lung carcinoma ; EPISPOT ; microfluidics ; early breast cancer ; circulating tumor cells (CTC) ; tumor-initiating cells (TICs) ; immunomodulation ; xenograft models ; CTC-derived xenografts ; malaria ; circulating tumor cells (CTCs) ; clinical utility ; exosomes ; liquid surgery ; ctRNA ; CTCs ; epithelial–mesenchymal transition ; targeted therapy ; hematological cells ; gene expression analysis ; hepatocellular carcinoma (HCC) ; breast cancer ; EpCAM enrichment ; prostate cancer ; CTC ; abiraterone ; fibronectin ; CTC-derived ex vivo models ; CTMat ; chromogranin A ; CTM ; exosome ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; ultrasonography ; elastography ; anti-HBV therapy ; pediatric ; WFUMB ; measurement variability ; tendon stiffness ; pancreas ; patellar positions ; point of care ultrasound ; time of day ; chronic hepatitis B ; quantification ; chronic hepatitis C ; EFSUMB ; stiffness ; liver cirrhosis ; liver fibrosis ; computer-aided diagnosis (CAD) ; guideline ; liver stiffness ; Achilles tendon ; bending energy ; ultrasound elastography ; acoustic radiation force impulse ; tendinopathy ; texture analysis ; power spectrum ; magnetic resonance imaging ; strain ratio ; thyroid cancer ; prior activity ; direct acting antivirals ; strain quantification ; patellar tendon ; shear wave elastography (SWE) ; cine-tagging ; cirrhosis ; health care ; shear wave elastography ; Crohn’s disease ; contrast enhanced ultrasound ; HCV core antigen ; shear modulus ; therapy ; ultrasound ; supersonic shear imaging ; carcinoma ; quantitative ; leg dominance ; viral hepatitis C ; strain elastography ; endoscopic ultrasound (EUS) ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC955-962 ; South America ; Papua New Guinea ; Cambodia ; Laos ; prevention ; environmental ; Seychelles ; Africa ; India ; Lao PDR ; western Indian Ocean ; animal ; treatment ; Hong Kong ; transmission modes ; Madagascar ; Thailand ; Middle East ; bacteriology ; Vietnam ; public awareness ; Burkholderia ; MLST ; Sri Lanka ; melioidosis ; veterinary ; South Asia ; mortality ; Caribbean ; Australia ; Central America ; Myanmar ; Malaysia ; awareness ; Réunion ; diagnosis ; Mauritius ; Melioidosis ; clinical ; tropical medicine ; B. pseudomallei ; Singapore ; Oceania ; epidemiology ; China ; genomics ; Burkholderia pseudomallei ; surveillance ; Philippines ; environment ; Bangladesh ; Mexico ; Indonesia ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RJ1-570 ; screening ; attention deficit hyperactivity disorder ; medical education ; sleep disturbance ; narcolepsy ; mental health ; circadian disturbance ; schizophrenia ; teenagers ; psychosis ; sleep disorders in ASD ; pediatric sleep ; executive functions ; children ; autism spectrum disorder ; multidisciplinary ; adolescents ; traumatic brain injury ; sleep problems ; comorbidities in ASD ; anxiety ; adolescence ; pediatric intensive care unit ; adolescent ; attention deficit disorder ; Theory of Mind ; arousal ; social functioning ; sleep–wake disorders ; mechanical ventilation ; child psychiatry ; learning ; Acute illness ; non-pharmacologic management ; sedation ; sleep ; electroencephalography (EEG) ; delayed sleep phase ; anticipatory guidance ; behavior ; obstructive sleep apnea ; medications for sleep disorders in ASD ; Attention Deficit Hyperactivity Disorder (ADHD) ; cannabis ; autism ; insomnia ; interventions ; sleep disordered breathing ; emotional information processing cognition ; attention ; cognitive behavioral therapy for insomnia (CBT-I) ; depression ; post-traumatic stress ; melatonin ; psychiatric disorders ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; polyphenols ; antioxidants ; inflammation ; prevention of non-communicable diseases ; flavonoids ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; coronary artery disease ; n/a ; glucocorticoid receptor ; antigen presentation ; analgesia ; chemotherapy ; locus coeruleus ; Sirtuin 1 ; thiol groups ; Heme Oxygenase-1 ; Betula etnensis Raf. ; heme oxygenase 1 ; tolerance ; heme oxygenase ; atherosclerosis ; nitric oxide ; caloric restriction ; liver ; carbon monoxide ; ER stress ; heme oxygenase-1 ; mineralocorticoid receptor ; Type 1 diabetes mellitus (T1D) ; Gamma-Glutamyl-Cysteine Ligase (GGCL) ; angiotensin II ; bilirubin ; Heme oxygenase-1 (HO-1) inducers ; Inducible nitric oxide synthase (iNOS) ; HO-1 activity inhibitor ; ferroptosis ; Myristica fragrans kernels ; glutathione ; high-pressure gas ; apoptosis ; HO-1 ; diabetes mellitus ; Caffeic acid phenethyl ester (CAPE) ; carotid plaque ; ischemia–reperfusion injury ; ANTIGEN presenting cell ; LPS ; endoplasmic reticulum stress ; hemoglobin ; Pancreatic oxidative damage ; Colon cancer ; inflammation ; reactive oxygen species ; inflammatory pain ; paracetamol ; cardiomyopathy ; heme oxigenase-1 ; adipocytes ; sirtuin 1 ; peripheral artery disease ; PGC-1? ; heme ; Reactive oxygen species (ROS) ; metformin ; GR ; prostate cancer ; NF-?B ; hyperbilirubinemia ; iron ; Tet-ON system ; lung preservation ; oxidative stress ; Gunn rats ; Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; QH301-705.5 ; RM1-950 ; galectins in therapy ; galectins and cancer ; galectins ; galectin-8 ; galectin-9 ; galectins in diagnosis ; galectins and immunity ; galectins and human diseases ; galectin-3 ; galectin-1 ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Coreopsis lanceolata L. ; UV-Vis ; methanogenesis ; Lythraceae ; flavanone ; grape marc ; TDDFT ; Ephedra sinica ; macrocyclic oligomer ; triple-negative breast cancer ; antioxidant ; purple prairie clover ; chalcone ; neuraminidase ; fatty acid synthase ; (?)-epigallocatechin gallate ; epidermal growth factor ; NMR spectroscopy ; Aluminum ion ; Onagraceae ; Hydrangea macrophylla ; synthetic analogues ; blue color development ; amyloid-? peptide ; FTIR ; oseltamivir carboxylate ; quantitative NMR ; phloroglucinolysis ; thin layer chromatography ; European historic leathers ; FASN inhibition ; ECD ; colorimetric tests ; taxanes ; cynandione A ; conservation method ; 5-O-caffeoylquinic acid ; ellagitannin ; PC12 ; condensed tannin ; Trapa taiwanensis Nakai ; 1H-NMR ; Acacia ; (?)-epigallocatechin 3-gallate ; Geranium thunbergii ; condensed tannins ; immunomodulatory effect ; Acacia mearnsii bark ; Escherichia coli ; oligomer ; Horner–Wadsworth–Emmons reaction ; lung tumor ; Aspergillus fumigates ; in vitro batch fermentation ; metal complex ; Myrtaceae ; Cynanchum auriculatum ; molecular interactions ; phenolic glycoside ; bamboo leaf extract ; stability ; Microsporum canis ; Cynanchum wilfordii ; thiolysis ; anti-inflammation ; hydrolysable tannin ; geraniin ; NGF ; polyphenol ; revision ; ESI-mass ; bioactivity ; antifungal activities ; interferon-? ; antitumor effect ; tannin composition ; oenothein B ; zanamivir ; 2-O-?-laminaribiosyl-4-hydroxyacetophenone ; anticancer activity ; proanthocyanidin ; vegetable tanning ; Dittrichia viscosa ; differentiation ; aurone ; antioxidants ; protein precipitation ; apoptosis ; polyphenolic FASN inhibitors ; forage legume ; biological activities ; ultrahigh-resolution negative mode MALDI-TOF mass spectrometry ; overlay method ; spectroscopy ; wattle tannin ; immune checkpoint ; hormesis ; 3-O-glucosyldelphinidin ; gallotannin ; proanthocyanidins ; fatty acids ; flavonol ; inhibition ; structure ; Candida spp. ; Malassezia spp. ; ORAC assay ; neuroprotection ; crystal structure ; tannins ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC321-571 ; epilepsy ; glioblastoma multiforme ; ADHD ; n/a ; prefrontal cortex ; regainers ; functional neuroimaging ; malignant glioma ; nutrients ; caffeine ; children ; inflammation ; working memory ; cytokines ; modified Atkins diet ; fish intake ; insulin resistance ; transpulmonary administration ; obesity ; maintainers ; electroencephalography ; Alzheimer’s disease ; omega-3 fatty acids ; diet-deficient ; weight loss maintenance ; neural processing ; hippocampal neurogenesis ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; n/a ; transient receptor potential channels ; photochromic ligands ; elementary immunology ; Purkinje cell ; EPSC ; substance P ; chemicals ; organ toxicity ; lymphocytes ; HSP70 ; physiology ; bioavailable ; inflammatory bowel disease ; platelets ; pollutants ; yeast ; regulatory T cells ; kinase ; Saccharomyces cerevisiae ; manganese ; cerebellum ; TRP channel ; NHERF ; inflammation ; nanoHPLC-ESI MS/MS ; TRPM7 ; chemical probes ; TRPM8 ; dorsal column nuclei ; TRPV2 ; TRPV3 ; calcitonin gene-related peptide ; TRPV1 ; ion channels ; transient receptor potential ; 2D gel electrophoresis ; MALDI-TOF MS(/MS) ; TRPV4 ; overproduction ; sulfur mustard ; oxidative stress ; graft versus host disease ; menthol ; topical ; chemosensor ; AP18 ; calcium signalling ; mucosal epithelium ; cuneate nucleus ; production platform ; TRPC channels ; ulcerative colitis ; channel structure ; xerostomia ; neutrophils ; cardiovascular system ; TRPC5 ; TRPC6 ; TRPC3 ; TRPC4 ; calcium signaling ; protein purification ; adipose tissue ; transient receptor potential (TRP) channels ; sodium ; TH17 ; diacylglycerol ; hypersensitivity ; TRPY1 ; GABAB ; HEK293 ; thrombosis ; ion channel ; TRPC ; pathophysiology ; SMAD ; toxicology ; endothelium ; calcium ; proteomics ; TRPA1 ; salivary glands ; TRP channels ; lipid mediators ; sensors ; radiation ; TRPM4 channel ; human medulla oblongata ; mGluR1 ; small molecules ; TRPC3 pharmacology ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; n/a ; liver graft injury ; HFE ; neurokinin ; chemotherapy ; intestinal tumors ; therapeutic targets ; biliary tract carcinoma ; hepatocellular carcinoma ; clinical trial ; cell adhesion molecules ; colorectal cancer ; biomarkers ; phenotypic mosaics ; gastrointestinal oncology ; Asian Cancer Research Group (ACRG) ; biomarker ; psychosocial support ; precision therapy ; pancreatic carcinoma ; precision medicine ; Liver transplantation ; predictive biomarkers ; CD274 ; cholecystokinin ; The Cancer Genome Atlas (TCGA) ; gastrin ; pembrolizumab ; immunotherapy ; gastrin-releasing peptide ; stereotactic body radiation therapy ; immunohistochemistry ; gastric carcinoma ; liver transplant ; CAM invasion assay ; intragraft gene expression profiles ; molecular profiling ; targeted therapy ; neurotensin ; intestinal disorder ; ramucirumab ; next-generation sequencing ; colorectal carcinoma ; tumor progenitor ; circulating tumor cells ; gastrointestinal malignancies ; bombesin ; trastuzumab ; somatostatin ; zebrafish ; G protein–coupled receptors ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; n/a ; screening ; single nucleotide polymorphism ; predictive and preventive approach ; PTEN ; cell-free DNAs ; fetal fraction ; gestational hypertension ; RASSF1 ; CDH1 ; RT-PCR ; cfDNA ; statistical models ; hematopoietic stem cell transplantation ; NanoString ; solid organ transplantation ; copy number variants ; sarcomas ; liquid biopsy ; obesity ; fetal DNA ; neutrophil extracellular traps ; mammography ; non-invasive prenatal testing ; ovarian cancer ; circulating miRNA ; pyrosequencing ; growth retardation ; preeclampsia ; gestational diabetes mellitus ; biomarker ; inflammatory bowel disease ; multi-level diagnostics ; PAX1 ; population study ; nuclease activity ; NETosis ; omics ; piRNA ; cell-free DNA ; prediction ; leiomyosarcomas ; network analysis ; NGS ; statistical methods ; circulating nucleic acids ; deletion/insertion polymorphism ; gender differences ; leiomyomas ; fetal growth restriction ; blood plasma ; exosomes ; miRNA ; pregnancy-related complications ; NIPT ; genetic marker ; cell-free nucleic acids ; extracellular vesicles ; expression ; next generation sequencing ; breast cancer ; individualized patient profile ; circulating tumor cells ; maternal serum screening ; personalized medicine ; embryo culture medium ; C19MC microRNA ; DNA ; cell-free RNAs ; z-score ; fetal cells ; microchimerism ; aging ; plasma ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; RC666-701 ; Neuroprotection ; Vascular diseases ; Novel drug development ; Signal transductions ; Clinical and translational research ; Free radicals/oxidative stress ; Platelet activation and thrombosis ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RJ1-570 ; non-IgE mediated allergy ; n/a ; randomized controlled trials ; infant ; “Probiotics”[Mesh] ; children ; safety ; therapeutic microbiology ; zinc ; prevention ; Lactobacillus ; cow’s milk protein ; constipation ; hepcidin ; infants ; Bifidobacterium ; Bifidobacterium breve ; allergy ; asthma ; functional abdominal pain disorders ; probiotic strain ; formula feeding ; probiotic ; nutritional programming ; 2?-fucosyllactose ; “Pregnancy”[Mesh] ; colic ; iron absorption ; bifidobacteria ; Newborn”[Mesh] ; breast feeding ; neonatal ; diversity ; acute diarrhea ; celiac disease ; human milk oligosaccharide ; acute gastroenteritis ; human milk oligosaccharides ; tolerance acquisition ; iron deficiency anemia ; infantile colic ; Lacto-N-neotetraose ; gluten free diet ; oligosaccharides ; preterm ; preterm infant ; microbial programming ; paediatrics ; Lactobacillus reuteri ; functional constipation ; protein hydrolyzed formulas ; oral rehydration solution ; gluten-free diet ; infant formula ; prebiotic ; Childhood Asthma Control Test ; microbiome ; intestinal transit time ; prebiotics ; sepsis ; probiotics ; microbiota ; “Infant ; lactobacilli ; human milk ; functional gastrointestinal disorders ; inulin ; fecal microbiota ; Bacillus clausii ; peak expiratory flow rate ; breast milk ; immunoglobulin E ; efficacy ; intestinal microbiota ; necrotizing enterocolitis ; pediatrics ; growth ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; lipids ; atherothrombosis ; interleukin 1? ; hepatic steatosis index ; cholesterol ; cytokines ; small LDL ; anti-apolipoprotein A-1 antibodies ; lipoproteins ; miR-33a ; microparticles ; microvesicles ; platelets ; chronic kidney disease ; endothelial cells ; sodium intake ; lipid metabolism ; HDL function ; GlycA ; acute coronary syndrome ; passive diffusion ; inflammation ; metabolic disorder ; type 2 diabetes mellitus ; leukocytes ; autoantibodies ; cardiovascular disease ; GRACE score ; Breast cancer ; triglycerides ; prognosis ; fatty liver index ; gut microbiota ; paraoxonase-1 ; canakinumab ; carbamoylation ; anti-apolipoprotein A-1 IgG ; 27-hydroxycholesterol ; C-reactive protein ; cholesterol homeostasis ; lipoprotein subfractions ; CANTOS ; myocardial infarction ; diabetic cardiomyopathy ; Type 2 diabetes mellitus ; retinol ; anti-apolipoprotein A-I autoantibodies ; non-alcoholic fatty liver ; large VLDL ; familial hypercholesterolemia ; lipoprotein metabolism ; free thiols ; phospholipid transfer protein activity ; obesity ; foam cells ; cardiovascular events ; atherosclerotic cardiovascular disease (ASCVD) ; biomarkers ; cholesterol-lowering therapies ; trimethylamine N-oxide related metabolites ; adipose tissue ; nuclear magnetic resonance spectroscopy ; biomarker ; metabolic syndrome ; HOMA-IR ; ANGPTL8 ; ANGPTL3 ; ANGPTL4 ; anti-apoA-1 IgG ; adiponectin ; retinol binding protein 4 ; HDL ; TLR2/4 ; visceral adipose tissue (VAT) ; LDL ; renal transplant recipient ; insulin resistance ; infrared spectroscopy ; C-statistics ; large very low density lipoproteins ; cholesterol efflux capacity ; coronary artery calcium score ; betaine ; LDL cholesterol ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; RC870-923 ; RB1-214 ; molecular biology ; diagnostics ; tumor markers ; Bladder cancer ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; marine functional foods ; vascular endothelial growth factor receptor-3 ; ultrafiltration ; lung fibrosis ; metabolic instability ; peptide fractions ; cembrane ; 3T3 fibroblasts ; Pinnigorgia sp. ; lymphatic endothelial cells ; bile salts ; caspase-3 ; cytokine ; hepatic stellate cells ; macrophage ; oral squamous cell carcinoma ; anti-inflammation ; MAPK ; fucoidan ; Jaspine B ; ACE-inhibition ; bioactivity ; sulfated galactan ; bioavailability ; ROS ; anti-angiogenesis ; briarellin ; neolignan ; radiation pneumonitis ; Pachyclavularia ; Lumnitzera racemosa ; apoptosis ; phomaketide A ; prodigiosin ; neutrophil ; intestinal permeability ; autophage ; secosterol ; octocoral ; amino acids composition ; phlorotannins ; cardiovascular-health ; antioxidant properties ; marine viva ; green seaweed ; protein enzymatic hydrolysate ; lymphangiogenesis ; edible brown algae ; briarane ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC581-607 ; RM1-950 ; Fungi ; Non-Tuberculous Mycobacteria ; Antibiotics ; Respiratory infections ; Pseudomonas aeruginosa ; Bronchiectasis ; Microbiome ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; epidemiology ; post-vaccine ; novel mechanism ; cancer ; tumour virus ; emerging ; undiscovered cancers/viruses ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; leukemia ; n/a ; biodistribution ; glycoalkaloids ; insect heart ; Solanum melongena L. ; antibacterial ; alkaloid ; ?-carboline ; Ovarian cancer ; Chelidonium majus ; secondary metabolites ; lindoldhamine ; livestock ; insect ; chanoclavine ; bisbenzylisoquinoline alkaloid ; cytotoxic activity ; Staphylococcus aureus ; antioxidant ; acid-sensing ion channel subtype 1a ; malonylated form ; HPLC-DAD ; ergot alkaloids ; nociception ; macrophage ; Arecoline ; Macleaya cordata ; antifungal ; neuropathic pain ; Corydalis lutea ; antiviral ; Curine ; lung cancer cells ; lipopolysaccharide ; Epichloë ; Meconopsis cambrica ; Berberis thunbergii ; SRC ; Dicentra spectabilis ; apoptosis ; endophyte ; natural sources ; dehydrocrenatidine ; neutrophil ; EGFR ; anticancer ; solamargine ; berberine ; isoquinoline alkaloids ; natural products ; Radix Aconiti Lateralis preparations ; short-term and long-term usage ; inflammation ; acute toxicity ; Mahonia aquifolia ; Palmatine ; sanguinarine ; Rutidea parviflora ; voltage-gated sodium channels ; cytotoxicity ; toxicology ; malonyl-solamargine ; alkaloids ; acetylcholinesterase ; beetles ; Fumaria officinalis ; antimicrobial activity ; solasonine ; FAK ; plant secondary metabolites ; di-ester diterpenoid alkaloids ; mAchR3 ; subchronic feeding study ; mono-ester diterpenoid alkaloids ; Tenebrio molitor ; Apoptosis ; reproduction ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; allergen ; n/a ; consumer home-test ; cereal grains ; non-communicable diseases ; health information ; trans-fatty acids ; health halo ; Aragón ; nutritional knowledge ; WTP ; Food Neophobia Scale (FNS) ; qualitative ; choice architecture ; plant extract ; organic consumer choices ; loglinear analysis ; exposure time ; purchase intentions ; food labelling ; functional ingredients ; greenhouse gas emissions ; non-communicable disease ; functional food ; food labels ; dietary fiber ; dining environment ; food choices ; changes in quality ; random forest ; local ; labeling ; segmentation ; cluster analysis ; nudging ; policy ; green tea ; United Kingdom ; health ; menu ; perceptions ; nutritional labels ; consumer research ; vitamins ; quantile regression ; nutritional claims ; information ; market success ; red wine ; qualified health claim ; alcohol content ; cross-cultural comparison ; health attitudes ; environmental information ; health consciousness ; nutrition claims ; health claim ; choice experiment ; organic dried strawberries ; emotional eating ; Brexit ; claim ; food choice ; pastries ; nutrition claim ; a discrete choice-based experiment ; trade-offs ; campus ; sustainability ; food neophobia ; nutrition ; lycopene ; nutrient labels ; yoghurt ; claims ; ultra-processed food products ; health claims ; willingness to pay ; changes in prices ; binary logistic regression ; new product development ; carrier foods ; consumer behavior ; college students ; focus groups ; clean labels ; consumer heterogeneity ; consumer ; organic ; consumer choice ; biscuits ; packaging ; label ; portion size ; older adult ; visual appraisal ; willingness to purchase ; experimental auction ; cancer ; consumer preferences ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; mass mortality ; marine biotoxin ; n/a ; alamethicin ; synergy ; seafood toxin ; patulin ; Paralytic shellfish toxin ; greater blue-ringed octopus ; Alexandrium catenella ; paralytic toxicity ; Ishigaki Island ; depuration ; okadaic acid ; serum biomarker ; ecotoxicological responses ; Hapalochlaena lunulata ; sydowinin A ; purification ; PSP outbreak ; southern Chile ; posterior salivary gland ; saxitoxin ; harmful algal blooms ; gliotoxin ; seafood safety ; uptake ; immunoaffinity column ; Alexandrium ; sydowinol ; chronic exposure ; environmental neurotoxin ; assimilation ; shellfish ; LC-MS ; biotransformation ; Perna viridis ; domoic acid ; fish ; algal toxin ; warming ; tetrodotoxin ; Mesodesma donacium ; combination index ; ultrahigh high performance liquid chromatography tandem mass spectrometry ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; in vitro dissolution ; microscopy imaging ; modulation ; ionotropic gelation ; laponite ; biowaiver ; beads ; model ; polymer/clay composite ; flow ; bioequivalence ; oral absorption ; curcumin ; P-gp ; liquid–liquid phase separation ; absorption ; large bowel ; dissolution ; Ussing chamber ; swelling ; fimasartan ; volume ; dexketoprofen ; gastrointestinal simulator ; transit ; controlled release formulations ; experimental and computational permeability methods ; magnetic resonance imaging ; GastroPlus™ ; in vitro–in vivo correlation (IVIVC) ; diltiazem ; MRI ; gut ; in vitro systems ; CYP3A4 ; poorly water-soluble drugs ; regional absorption ; intestinal permeability ; butyric acid ; intestinal drug absorption ; gastrointestinal absorption ; Biopharmaceutics Classification System (BCS) ; anti-inflammatory ; in vivo ; colon microbiota ; lipid-based formulations ; in situ single-pass perfusion ; metabolites ; biorelevant media ; fluconazole ; colon delivery ; modeling study ; mathematical modeling ; motility ; gellan gum ; gastrointestinal drug release ; large intestine ; lipolysis ; regional drug absorption ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; UV-absorbing compound ; lifespan ; oligosaccharides ; mast cells ; AP-1 ; antioxidant activity ; phlorotannin ; pH-thermo stability ; microalgae ; Hizikia fusiforme ; skin-aging ; MAPKs ; bioactive ; Fucofuroeckol-A ; carbohydrates ; antioxidant ; mitochondrial function ; natural ; photoprotection ; anti-inflammation ; keratinocytes ; heme oxygenase-1 ; fucoidan ; marine algae ; Biological Effective Protection Factors (BEPFs) ; 9-cis-?-carotene ; MMP ; radical scavenging activity ; Ecklonia stolonifera ; nuclear factor erythroid 2-related factor 2 ; Drosophila melanogaster ; anti-allergy ; miiuy croaker (Miichthys miiuy) ; UVB ; sunscreen ; mobility ; cosmeceuticals ; collagen hydrolysates ; mycosporine-2-glycine ; scale ; cosmetics ; anti-aging ; anti-protein-glycation activity ; pepsin-soluble collagen (PSC) ; inflammation ; sulfated polysaccharides ; UV- mediated action spectra ; skin health ; anti-oxidation ; ageing ; substances ; low molecular-weight ; cytoprotection ; MMPs ; 5-dihydroxybenzaldehyde ; acid-soluble collagen (ASC) ; marine collagen peptide ; Dunaliella salina ; NF-?B ; mycosporine-like amino acids ; photoprotective ; monosaccharides ; degranulation ; ultraviolet-B ; 3-bromo-4 ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; Trichoderma ; n/a ; photodegradation product ; physical decontamination ; growth performance ; toxigenic Fusarium ; curcumin ; mitigation ; Aspergillus flavus ; food and beverage ; ascladiol ; biological control ; antioxidant capability ; trichothecene ; bioprospecting ; turkey ; processing ; chicks ; Sporobolomyces sp. IAM 13481 ; mycotoxins ; epimer ; Tri101 ; enzymes ; neutral electrolyzed water ; antioxidant function ; purification ; ameliorating effects ; aflatoxin-degrading enzyme ; chemical decontamination ; desoxypatulinic acid ; furan rings ; maize ; atmospheric pressure ; biotransformation ; estrogen receptor (ER) ; oxidative stress ; decontamination ; Bacillus shackletonii ; hyssop ; DBD ; degradation ; TQEF-MS/MS ; CYP450 ; enzymatic detoxification ; low temperature plasma ; Fusarium ; AFBO–DNA ; modified mycotoxin ; Bacillus subtilis ANSB060 ; polarity ; thermal treatment ; serum hormones ; mycotoxins mitigation ; mycotoxin ; zearalenone (ZEA) ; cell viability ; detoxification ; patulin ; biodegradation ; interactions ; intracellular and extracellular enzymes ; Bacillus licheniformis CK1 ; deoxynivalenol ; aflatoxins ; aflatoxin B1 ; biological decontamination ; Corylus avellana ; molecular ; Pichia caribbica ; mild technologies ; microbial patulin degradation ; enzyme ; proteomics ; fatty acids ; spores of Ganoderma lucidum ; inhibition ; residue ; food safety ; cold atmospheric pressure plasma technology ; application ; post-weaning female piglets ; laccase ; aflatoxin biodegradation preparation ; Aflatoxin B1 ; microorganism identification ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; leukemia ; angucycline glycosides ; steroidal glycoside ; antitumor ; deep-sea ; antibacterial ; anticoagulant ; saquayamycin ; marine invertebrate ; triterpene glycoside ; glycosides ; carbohydrate ; polyhydroxysteroidal glycoside ; glycosphingolipids ; triterpene glycosides ; cytotoxic activity ; metabolite profiling ; magnumosides ; antioxidant ; angiogenesis ; Poecillastra compressa ; cucumarioside ; antifungal ; nonholostane ; Eupentacta fraudatrix ; angucycline ; urdamycin ; marine ginseng ; sponge ; antimicrobial ; holostane ; apoptosis ; cholesterol sulfate ; SMMC-7721 ; metastases ; Culcita novaeguineae ; natural products ; marine organisms ; liquid chromatography–tandem mass spectrometry ; anti-inflammatory ; tumor growth ; mass spectrometry ; ESI ; total synthesis ; starfish ; sea cucumber ; cytotoxic ; cytotoxicity ; saponins ; Neothyonidium magnum ; glycolipids ; glycoglycerolipids ; Conus pulicarius ; MALDI ; Streptomyces ; glycoside ; radioactive irradiation ; frondoside A ; LC-MS ; invasion ; Holothuroidea ; saponin ; bioactive compounds ; cancer ; structure elucidation ; mangrove-derived Streptomyces ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; RC254-282 ; Phytochemicals ; Natural products ; Cancer therapy ; Dietary agents ; Cancer prevention ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; RC254-282 ; tumor initiation and development ; cancer therapy ; circulating microRNA ; microRNA ; diagnosis ; biomarker ; exosome ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC31-1245 ; gastrointestinal diseases ; sterile inflammation ; n/a ; Staphylococcus spp. ; etiopathogenesis ; colitis ; Escherichia coli ; bacteriophages ; atopic dermatitis ; intravenous immunoglobulin G ; adaptive immunity ; 16S rRNA gene ; vaginal microbiota ; modularity ; innate immunity ; gut-liver axis ; disease activity ; immune system ; cytokines ; commensals ; Staphylococcus aureus ; dysbiosis ; fecal transplantation ; TLR mimicry ; etanercept ; dextran sulfate sodium ; CAR T-cell ; 3-dihydroxy-4-methoxyBenzaldehyde ; chemo free treatment ; Staphylococcus epidermis ; rheumatoid arthritis ; microbiome ; co-occurrence network ; immune epigenetics ; 2 ; autoimmunity ; superoxide dismutase ; precision medicine ; metabolism ; adoptive cell transfer (ACT) ; gut barrier ; antibiotics ; checkpoint inhibitors ; probiotics ; microbiota ; Candida albicans ; Enterococcus faecalis ; chronic liver diseases ; TCR ; anaerobic bacteria ; HSV2 ; bacteriocins ; methotrexate ; microbial interactions ; T cells ; virus ; mice ; lymphoid malignancies ; HPV ; macrophages ; anti-TNF-? ; inflammation ; chondroitin sulfate disaccharide ; immunotherapy ; genomics ; immuno-oncology ; diet ; aerobic bacteria ; immunological niche ; melanin ; health ; chemokines ; gut microbiota ; cutaneous immunity ; HIV ; TIL ; cancer ; global network ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; n/a ; decontamination ; superheated steam ; quercetin glycosides ; antagonism ; mode of action ; corn ; Botrytis sp. ; AITC ; binding ; degradation ; brine shrimp bioassay ; apple pomace ; nanoparticles ; enzymatic detoxification ; Bacillus ; estrogen response element ; Fusarium ; biological detoxification ; abiotic factors ; stability ; fumonisin esterase FumD ; mycotoxigenic fungi ; Aspergillus flavus ; Aflatoxin M1 ; Fusarium graminearum ; milk ; Penicillium digitatum ; biocontrol agents ; biological control ; dry-cured ham ; mycotoxin reduction ; Fusarium sp. ; enzyme kinetics ; Penicillium nordicum ; Satureja montana ; roasted coffee ; fermentation ; crisp biscuit ; detoxification ; essential oils ; gene expression ; probiotics ; zearalenone ; mycotoxins ; degradation products ; Geothrichum citri-aurantii ; garlic-derived extracts ; Zearalenone ; biodegradation ; EU limits ; storage ; Origanum virens ; aflatoxin ; fungal growth reduction ; green chemistry ; Penicillium italicum ; deoxynivalenol ; ?-Fe2O3 ; ochratoxin A (OTA) ; wheat ; cell-free extracts of Aspergillus oryzae ; photocatalysis ; wheat quality ; post-harvest phytopathogen ; cold plasma ; pinnatifidanoside D ; ochratoxin A ; oats ; cell proliferation ; estrogen receptor ; Penicillium verrucosum ; pig production performance ; phloridzin ; maize ; biotransformation ; fumonisin ; fungi ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; n/a ; lipids ; cathepsins ; neurodegeneration ; tocilizumab ; SGBS adipocytes ; chemerin receptors ; cholesterol ; metabolically healthy obese ; energy metabolism ; adipose-brain axis ; EP3 receptor ; leptin ; rheumatoid arthritis ; excessive gestational weight gain ; in vitro fat regain ; secreted frizzled-related protein 5 ; PCOS ; EP4 receptor ; leukocyte ; exchange protein directly activated by cAMP isoform 2 (EPAC2) ; extracellular remodeling ; insulin ; osteoarthritis ; lipid metabolism ; fat mass ; Tango bioassay ; fatty liver ; free fatty acids ; label-free proteomic profiling ; interleukin(IL)-33 ; sick fat ; polycystic ovary syndrome ; early-life programming ; inflammation ; gestational diabetes ; glucose restriction ; adipokines ; neonatal anthropometry ; epicardial adipose tissue (EAT) ; oestrous cycle ; Cardiovascular Diseases (CVDs) ; triglycerides ; G protein-coupled receptor 1 ; testicular pathologies ; prognosis ; ovary ; ICU ; biologic activity ; preeclempsia ; adipokine ; critical illness ; early pregnancy ; myokine ; liver steatosis ; C-C chemokine receptor-like 2 ; testis ; stimulating growth factor 2 (ST2) ; pig ; fitness ; human granulosa cells ; obesity ; proteolysis ; annexins ; adipose tissue ; biomarker ; ghrelin ; brain health ; sepsis ; adiponectin ; rheumatic diseases ; chemokine-like receptor 1 ; follicular fluid ; glucose homeostasis ; resistin ; Nonalcoholic fatty liver disease ; prostaglandin E2 (PGE2) ; visceral fat ; microglia ; weight regain ; complement factors ; alpha-fetoprotein ; polycystic ovary morphology ; chemerin ; cancer ; depression ; hypertension ; hypothalamus ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC109-216 ; n/a ; Cambodia ; schistosomiasis elimination ; chemotherapy ; Côte d’Ivoire ; systems thinking ; Schistosomiasis mansoni ; control and elimination ; neglected tropical diseases ; drug discovery ; systems epidemiology ; guidelines ; schistosomiasis ; Central Africa ; goals ; mapping ; Africa ; cattle ; zoonosis ; systematic non-compliance ; Lao PDR ; Sm14 ; POC-CCA ; planorbidae ; complexity ; distribution ; remote-sensing ; Neotricula aperta ; sanitation ; Biomphalaria glabrata ; Schistosomiasis ; international space station ; Mayuge ; elimination ; spatio-temporal epidemiology ; goats ; FABP ; artemether ; interdisciplinarity ; praziquantel ; soil-transmitted-helminthiasis ; Caribbean ; health education ; snail ; Schistosoma haematobium ; snail resistance ; 28S ribosomal DNA ; WIPO Re:Search ; intermediate snail host ; Schistosoma malayensis ; Gabon ; transmission ; soil-transmitted helminths ; combination therapy ; S. mansoni ; climate change ; domestic animals ; Schistosoma mansoni ; diagnosis ; Schistosoma japonicum ; leishmaniasis ; modelling ; public-private partnerships ; GIS ; ECOSTRESS ; young adults ; Oncomelania hupensis ; PCR ; Bulinus truncatus ; gene drive ; worldview ; S. japonicum zoonosis ; coverage rate ; phylogeography ; cross-sector collaboration ; epidemiology ; preventive chemotherapy ; MDA coverage ; China ; operational research ; transmission control ; satellite ; high-sensitivity diagnostics ; loop-mediated isothermal amplification (LAMP) ; sheep ; polymerase chain reaction ; BIO Ventures for Global Health ; bovines ; Kato-Katz ; vaccine development ; treatment-opportunities ; Philippines ; buffalo ; Schistosoma mekongi ; control ; Schistosoma ; vector control ; vaccine ; parasite ; Asia ; transgenic snail ; snail control ; DNA ; capacity-building ; Uganda ; pooled samples ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; chitosan ; maltodextrin ; Caco-2 cells ; alkyl lactate ; mucosal drug delivery ; thermogelling polymers ; buccal mucosa drug delivery ; drug delivery ; triple co-culture model ; oral lichen planus ; mucoadhesive polymers ; cyclodextrins ; paediatric ; mucoadhesion ; nanoparticles ; pectin ; furosemide ; oral lyophilisates ; films ; wound healing ; pluronic f127 ; interpolymer complexes ; transmucosal permeations ; Alzheimer’s disease ; biocompatibility ; poly (vinylpyrrolidone) ; mucosal membranes ; scanning electron microscopic images ; pioglitazone ; hydrogel ; resuspendibility ; thermoresponsive polymers ; mucoadhesive microspheres ; trimethyl chitosan ; Candida albicans ; xanthan gum ; omeprazole ; texture profile analysis ; acrylated chitosan ; mucoadhesive ; clotrimazole ; clobetasol ; Carbopol® ; hydroxypropyl cellulose ; electrospinning ; chitosan derivatives ; in vitro permeability ; l-arginine ; resveratrol ; cytotoxicity ; retention ; thiolated hyaluronic acid ; Carbopol ; mucoadhesive polymer ; rheology ; Eudragit® E PO ; detachment force ; chitosan-catechol ; controlled release ; PLGA-PEG ; liposphere ; gellan gum ; storage and loss moduli ; thiolated chitosan ; interpolyelectrolyte complex ; poly(2-ethyl-2-oxazoline) ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RD1-811 ; n/a ; AERD ; pediatric ; adenoidectomy ; chronic rhino sinusitis ; cystic fibrosis ; biofilm ; nasal polyps ; aspirin exacerbated respiratory disease ; eosinophilia ; eosinophil ; adenoiditis ; nasal poly ; endoscopic sinus surgery ; aspirin desensitization ; central compartment atopic disease ; medial maxillectomy ; allergy ; diagnosis ; adenoids ; asthma ; allergic fungal rhinosinusitis ; nasal polyposis ; Samter’s Triad ; medical management ; sinus surgery ; chronic rhinosinusitis ; sinusitis ; allergic rhinitis ; rhinosinusitis ; polyposis ; hyposmia ; bic Book Industry Communication::M Medicine

Keywords: QD1-999 ; Toxicology ; Chemistry ; Biology ; Material Science ; Nanofibers ; Nanotechnology ; thema EDItEUR::P Mathematics and Science::PN Chemistry

Keywords: R5-920 ; RM1-950 ; human liver microsomes ; alcohol addiction ; UGT ; ultra-high-pressure liquid chromatography ; adalimumab ; procainamide ; LC-MS/MS ; DA-9805 ; paeonol ; LC-QTOF-MS/MS ; YRA-1909 ; chlorogenic acid ; immunoprecipitation ; Eurycoma longifolia ; CYP ; caffeic acid ; rat ; pharmaceutical excipient ; Korean red ginseng extract ; Stauntonia hexaphylla leaf extract ; bioanalysis ; HPLC-MS/MS ; B6 ; eurycomanone ; bioavailability ; drying technology ; GB3 ; diclofenac ; 129-Glatm1Kul/J ; aglycone ; caffeic acid O-glucuronides ; organic anion transporting polypeptide ; protein precipitation ; metabolic stability ; Fabry disease ; biopharmaceuticals ; imperatorin ; neochlorogenic acid ; gastric ulcer ; saikosaponin a ; hair ; anthraquinone ; acetyl tributyl citrate ; pharmacokinetics ; brain distribution ; mematine ; ethyl glucuronide ; pharmacokinetic ; loxoprofen ; liquid chromatography-quadrupole TOF MS ; glucuronidation ; esomeprazole ; metformin ; cytochrome P450 ; glycoside ; AUDIT score ; protein stability ; efficacy ; LC-HR/MS ; cryptochlorogenic acid ; aceclofenac ; drug interaction ; liquid chromatography-tandem mass spectrometry ; Osthenol ; plasma ; N-acetylprocainamide ; diabetes ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; acupuncture ; sciatica ; low back pain (LBP) ; uterine cancer ; osteoarthritis ; myopia ; pulse diagnosis ; depression ; moxibustion ; post-stroke ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; precision medicine informatics ; n/a ; drug sensitivity ; chromatin modification ; cell lines ; biocuration ; neurodegeneration ; multivariate analysis ; artificial intelligence ; epigenetics ; missing data ; sequencing ; clinical data ; class imbalance ; integrative analytics ; algorithm development for network integration ; deep phenotype ; non-omics data ; feature selection ; Gene Ontology ; miRNA–gene expression networks ; omics data ; plot visualization ; Alzheimer’s disease ; tissue classification ; epidemiological data ; proteomic analysis ; genotype ; RNA expression ; indirect effect ; multi-omics ; dementia ; multiomics integration ; data integration ; phenomics ; network topology analysis ; challenges ; transcriptome ; enrichment analysis ; regulatory genomics ; scalability ; heterogeneous data ; systemic lupus erythematosus ; database ; microtubule-associated protein tau ; disease variants ; genomics ; joint modeling ; distance correlation ; annotation ; phenotype ; direct effect ; curse of dimensionality ; gene–environment interactions ; logic forest ; machine learning ; KEGG pathways ; multivariate causal mediation ; amyloid-beta ; bioinformatics pipelines ; support vector machine ; pharmacogenomics ; candidate genes ; tissue-specific expressed genes ; cognitive impairment ; causal inference ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Infectious disease ; one health ; rabies ; veterinary medicine ; prophylaxis ; virus ; zoonosis ; public health ; vaccination ; wildlife ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RJ1-570 ; symptom management ; life-limiting disease ; quality of life ; hospice ; pediatric palliative care ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; treatment ; collateral affectors ; costs ; screening ; endpoints ; trail design ; ovarian cancer ; efficacy ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; chitosan ; encapsulation ; gold nanoparticles ; pH/redox-responsive ; bolaform amphiphilic lipids ; irradiation cycles ; drug delivery ; caries prevention ; bolalipids ; nanocage ; natural extracts ; astaxanthin ; eukaryotic vaults ; nanoparticles ; amphiphilic random copolymers ; zoledronic acid ; triggered release ; nanohydrogels ; doxorubicin ; vapor nanobubbles ; curcumin ; gold reduction ; diffusion barrier ; liposomes ; hyaluronan ; laser treatment ; nanoparticle ; mixed polymeric micelles ; protein self-assembly ; squalene ; antimicrobial photodynamic therapy ; self-assembly ; hydrogel ; C-peptide ; polyelectrolyte complexes ; siRNA delivery ; drug delivery system ; biofilms ; pulmonary surfactant ; multidrug resistance ; drug delivery systems ; nano-assemblies ; photo-thermal therapy ; anticancer ; polypeptides ; graphene quantum dots ; nanovesicles ; aerogel ; resveratrol ; intracellular therapy ; Oral antimicrobials ; syringeable implant ; trehalose ; betulinic acid ; in situ gelling systems ; autophagy induction ; chorioallantoic membrane model ; controlled release ; diabetes ; oxidative stress ; localized heating effect ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; the elderly ; regression analysis ; walking event ; green space ; missing data ; crop residue burning ; correlation analysis ; imputation ; physical environment ; crowdedness ; Guangzhou ; mobile phone data ; GPS trace ; noise pollution ; mental disorders ; Beijing ; urban leisure ; environmental exposure ; environmental context cube ; subway stations ; air pollution exposure ; long-distance walking ; car ownership ; multilevel model ; CHAS ; ecological momentary assessment ; cycling for transportation ; cognitive aging ; 3SFCA ; interannual and seasonal variations ; well-being experience ; personal projects ; spatial spread ; E2SFCA ; activity space ; catchment areas ; structural equation modeling ; transport modes ; greenspace exposure ; health ; train stations ; human mobility ; quantile regression ; the neighborhood effect averaging problem (NEAP) ; emissions estimation ; taxi GPS trajectories ; real-time traffic ; primary healthcare ; rail travel ; spatial accessibility ; commuting route ; GPS ; urban planning ; environmental health ; Brazil ; EMA ; geographical accessibility ; big data ; dynamic assessment ; obesity ; healthcare accessibility ; population demand ; the uncertain geographic context problem (UGCoP) ; geographic impedance ; collective leisure activity ; multimodal network ; GIS ; 2009 influenza A(H1N1) pandemic ; UGCoP ; environmental exposures ; spatial data ; the uncertain geographic context problem ; Singapore ; built environment ; adults ; time-weighted exposure ; geographic imputation ; Public Participatory GIS (PPGIS) ; access probability ; life-course perspectives ; China ; walking ; active travel ; foodscape exposure ; car use ; food environment ; fuel consumption ; ageing ; Healthcare services ; road traffic accidents ; space-time kernel density estimation ; multilevel Bayesian model ; environmental context exposure index ; spatial autocorrelation ; PM concentrations ; physical activity ; bike paths ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Pediatrics ; Pain ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Therapy ; Treatment ; Diet therapy ; Eating disorders ; Mental health ; Health impact assessment ; Obesity/overweight ; Behavioural therapy ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; fusogenic ; small molecule ; cancer vaccine ; peptide-drug conjugate ; protein–protein interaction ; anticancer peptide ; tetrapeptides ; drug discovery ; ginkgo nuts ; prostaglandin F2? ; macrocyclic peptide ; melanocortins ; Toll-like receptor ; polo-box domain ; endosomolytic ; structure-activity ; free energy calculation ; peptide ; autophagy ; synthetic vaccine ; small antimicrobial peptides ; azapeptides ; classification ; multifunctional ligands ; cytoprotective ; polycationic -amino acids ; N-acetylated Pam2Cys ; Pam2Cys ; disulfide-rich scaffold ; d-amino acid scan ; VEGF165 ; antibiotics ; hyperdisulfide ; peptides ; random forest ; pseudosubstrate ; influenza hemagglutinin ; Ranalexin ; ?-ginkgotide ; LIR motif ; bioconjugation ; peptide agonist ; GnRH ; molecular rotor dye ; sensor chip ; helix-breaker ; Plk1 ; antimicrobial activity ; molecular dynamics ; machine learning ; melanocortin-4 receptor ; kinase inhibitor ; support vector machine ; D-amino acid ; drug screen ; receptor desensitization ; diabetes ; opioids ; selectivity ; IP20 ; aza-amino acids ; bis-benzamide scaffold ; G?S signaling ; chemical linker ; MC4R ; LHRH ; ?-hairpin ; androgen receptor ; adjuvant ; high throughput screening ; receptor internalization ; peptide design ; ?-helix mimetics ; adaptogenic ; obesity ; cardiovascular profile ; hypoxia ; programmed cell death ligand protein 1 ; PKA ; neuropilin-1 ; preterm labor ; ?-sheet ; PKI ; MC3R ; myometrium contractions ; amphiphilic ; structure–activity relationship ; peptidomimetics ; combinatorial chemistry ; sepsis ; coactivator PELP1 ; OBOC ; mixed-mode pharmacology ; configuration ; peptide permeability ; triazole ; stapled peptide ; cysteine-rich peptides ; GLP-1 ; RBC lysis ; mixed pharmacology ; therapeutic peptides ; opioid ; peptidomimetic ; prostate cancer ; alanine scan ; lipidation ; peptide therapeutics ; cancer ; pharmacophore

Keywords: R5-920 ; RB1-214 ; modeling ; underwater vehicle ; gesture-based language ; text classification ; navigation and control ; motion constraints ; autonomy ; dynamics ; marine robotics ; unmanned surface vehicle ; field trials ; actuator constraints ; robust control ; fault detection and isolation ; remotely operated vehicle ; underwater manipulator ; intelligent control ; object obstacle avoidance ; submersible vehicles ; overcome strong sea current ; underwater robot ; maneuverability identification ; ROV ; Lyapunov stability ; VGI ; ocean research ; two-ray ; path loss ; obstacle avoidance ; parallel control ; approximated optimal control ; sliding mode control ; automation systems ; fault-tolerant control ; numerical calculation ; backstepping control ; deep learning ; unmanned underwater vehicle (UUV) ; underwater human–robot interaction ; aerial underwater vehicle ; thruster fault ; airmax ; position control ; cross-medium ; free space ; second path planning ; flow sensing ; underwater vehicle-manipulator system ; marine systems ; low-level control ; dynamic modelling ; kinematics ; vehicle dynamics ; WLAN ; viscous hydrodynamics ; fault accommodation ; RSSI ; nonlinear systems ; guidance ; simulation model ; artificial lateral system ; autonomous underwater vehicle ; typhoon disaster ; force control ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; epidemiology ; Cancer ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC666-701 ; postmortem biochemistry ; medulla ; animal models ; remodeling ; BNP ; PCSK9 ; guanylyl cyclase/natriuretic peptide receptor-A ; cardiorenal syndrome ; forensic medicine ; preserved ejection fraction ; kidney ; renin-angiotensin-aldosterone system ; atrial fibrillation ; vasopressor ; congestive heart failure ; atrial natriuretic peptide ; gene-knockout ; obesity ; heart failure ; angiogenesis ; adipose tissue ; vascular ; LDL receptor ; metabolic syndrome ; linkage analysis ; cardiometabolic disease ; cardiomyocyte ; cardiac dysfunction ; cardiac hypertrophy ; insulin ; lipid metabolism ; cGMP ; Idiopathic Pulmonary Arterial Hypertension (IPAH) ; Natriuretic Peptide Clearance Receptor (NPR-C) signaling ; gene-duplication ; renin–angiotensin system ; natriuretic peptides ; angiotensin receptor–neprilysin inhibitor ; cardiac remodelling ; ARNi ; NT-proBNP ; inflammation ; pulmonary arterial hypertension ; vascular homeostasis ; endothelial cell ; Atrial Natriuretic peptide ; natriuretic peptide ; vasodilator ; stroke ; genetic variants ; arterial hypertension ; fibroblast ; MANP ; hypertension ; guanylyl cyclase receptor A ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Q1-390 ; cell encapsulation ; tissue engineering ; bioresponsive extracellular matrix mimetic ; hydrogel ; cell adhesion ; high throughput screening ; polyampholyte ; biphasic ; antifouling ; bioprinting ; bioactive ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; n/a ; spider toxin ; hybrid immunogen ; channel-like pore-forming activity ; venom peptides ; chemotherapy ; piperidine heterocyclic amines ; computational docking ; insect immune system ; venom ; toxoplasmosis ; wasps ; ion channel structure ; mechanical allodynia ; Dinoponera quadriceps ; natural antibiotics ; bees ; acid-gated currents ; nematicide ; novel therapeutics ; toxins ; protons ; Hymenoptera venom ; ants ; chronic pain ; heart contractility ; transcriptome ; drug targets ; skin ; peptides ; LTQ Orbitrap Hybrid Mass Spectrometer ; cantharidin ; Centruroides limpidus Karch ; pilosulin-like peptide ; mechanism ; scorpion ; stent ; homology modelling ; amphipathic ?-helix structure ; Berberomeloe majalis ; mass spectrometric analysis ; phospholipases D ; Nav1.7 ; biotools ; metalloproteases ; myrmecology ; Tenebrio molitor ; antifeedant ; ixodicide ; virtual screening ; Loxosceles ; acid-sensing ion channels ; small hive beetle ; knottins ; Nav channel activity ; envenomation ; pharmacology ; Staphylococcus aureus ; spider venom ; scorpion venom ; insecticidal peptide ; Formicidae ; AMP ; de novo sequencing ; tertiapin ; leishmaniasis ; brown spider ; proteome ; keratitis ; Acinetobacter baumannii ; neuropathic pain ; bee venom ; bioinformatics ; ICK peptide ; human African trypanosomiasis ; automated patch-clamp ; Hymenoptera ; antimicrobial peptide ; LyeTxI-b ; linear cationic ?-helical peptide ; melittin ; Chagas disease ; mass spectrometry analysis ; neutralizing antibodies ; apoptosis ; protein–peptide interactions ; malaria ; pH regulation ; voltage-gated sodium channel ; venom toxicity ; insect neurotoxin ; solitary wasp ; oxaliplatin ; arthropod ; mastoparan ; cold allodynia ; pain target ; cutaneous disease ; pain ; NaV ; proteomics ; industrial biotechnology ; ant ; directed disulfide bond formation ; antivenoms ; blister beetle ; venom allergens ; ICK-like toxins ; Loxosceles spp. ; alternative treatment ; recombinant toxins ; FMRF-amide ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; method validation ; sirtuin 1 (SIRT1) ; arctic ; Cylindrospermopsin ; Microcystin-LR ; 16S rRNA gene ; astaxanthin ; secondary metabolites ; shotgun metagenomic sequencing ; time-resolved fluoroimmunoassay ; Histopathological evaluation ; cyanobacterial thresholds ; akinetes ; nutrient enrichment ; benthic mats ; cylindrospermopsin ; drinking water treatment plant ; blue-green algae supplements ; lettuce ; genotoxicity ; exposure ; bacterial community ; PCR ; microcystin-LR ; marine natural compounds ; ELISA ; [d-Leu1]Microcystin-LR ; Paracentrotus lividus ; tadpoles ; apoptosis ; 16S rRNA gene sequencing ; PSP toxins ; marine cyanobacteria ; hemolytic essay ; energy budget ; bioassays ; anatoxin-a ; Lithobates catesbeianus ; mixture ; reproductive toxicity ; cyanobacteria ; taste-and-odor compounds ; Procambarus clarkii ; drinking water ; saxitoxin ; resveratrol ; harmful algal blooms ; cytotoxicity ; phylogenetic analyses ; Yangtze estuary ; microcystin ; mutagenicity ; detection ; Artemia salina ; water source ; cyanotoxins ; microcystins ; in vitro ; marine sponges ; microcystin-LR (MC-LR) ; UPLC-MS/MS ; reservoir ; microbial metabolisms ; Aphanizomenon flos-aquae ; monoclonal antibody ; oxidative stress ; Nostocales ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC346-429 ; n/a ; analgesia ; quantitative phosphoproteomics ; neurodegeneration ; neuron ; neuronal circuits ; mating ; sex-specific differences ; AMPA receptor complex ; parallel reaction monitoring ; splicing ; phosphorylation ; peptidylglycine ?-amidating monooxygenase ; pherophorin ; Alzheimer’s disease ; neuroscience ; yohimbine ; synapses ; adolescence ; conformational antibody ; opioid receptors ; protein interaction networks ; Alzheimer’s Disease ; transmembrane AMPA receptor regulatory protein ; neuroproteome ; ethanol ; U1 snRNP ; mass spectroscopy ; morphine ; protein phosphatase-1 ; neuroproteomics ; axons ; reinstatement ; DIA ; voltage gated channels ; prohormone convertase ; postsynaptic density ; neuroimmune ; dendrites ; carboxypeptidase ; GPCR signaling ; CaMKII ; FGF14 ; SynCAM ; nicotinic receptor ; synaptic plasticity ; plasma ; serum ; corticosterone ; dopamine ; Receptor-type tyrosine-protein phosphatase zeta ; Ptprz1 ; PRM ; cell type ; schizophrenia ; laser capture microdissection ; synapse specificity ; LC-MS/MS ; mouse ; drug abuse ; synaptic cleft ; striatum ; Cadm ; cytokine ; spinophilin ; PSD ; trans-synaptic adhesion ; nicotine ; proximity labeling ; biomarkers ; addiction ; PKA ; synapse ; proteome ; signal peptide ; ventral tegmental area ; protein aggregation ; cerebrospinal fluid ; bioinformatics ; progressive ratio ; interactome ; subtilisin ; affinity chromatography ; basal ganglia ; cocaine ; targeted proteomics ; postsynaptic ; mass spectrometry ; connectome ; quantitative mass spectrometry ; biotinylation ; proteomics ; amphetamine ; autism ; data-independent acquisition ; excitatory/inhibitory tone ; neuropeptidomics ; matrix metalloproteinase ; cilia ; R-PTP-zeta ; cognitive impairment

Keywords: R5-920 ; RA1-1270 ; RM1-950 ; biomarks ; diagnosis ; mitochondrial respiratory chain (MRC) ; mitochondrial disorders ; biochemical parameters/markers ; oxidative stress ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; competence ; education ; pharmacy ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RK1-715 ; dog study ; root coverage ; n/a ; bone grafts ; aggregation ; enamel matrix proteins derivative ; bone substitutes ; periodontal surgery ; animal study ; ?-tricalcium phosphate ; bone regeneration ; combination therapy ; videoscope ; socket preservation ; guided tissue regeneration (GTR) ; biologics ; deproteinized bovine bone ; minimally invasive ; platelet-rich plasma ; platelets ; Alveolar ridge preservation ; periodontal regeneration ; Smart Dentin Grinder ; quality assurance ; tooth particles ; enamel matrix derivatives (Emdogain®) ; autogenous particulate tooth graft ; aggressive periodontitis ; spectrophotometer ; soft tissue management ; connective tissue graft ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC581-607 ; antibody drug conjugates ; bispecific antibodies ; engineered antibodies ; antibody-like scaffolds ; monoclonal antibodies ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC31-1245 ; bleomycin ; n/a ; regeneration ; antitumor efficacy ; lung cancer ; SOX2 ; leiomyosarcoma ; lung cancer (LC) ; nanoparticles ; cytokines ; hepatocellular carcinoma ; metabolic reprogramming ; hepatic stellate cells ; angiogenesis ; transforming growth factor-? ; anaplastic lymphoma kinase ; idiopathic pulmonary fibrosis ; growth factor ; pathogenesis ; cancer-associated fibroblasts ; fibrosis ; lipopolysaccharide ; DHA ; lncRNA ; SREBP-1 ; YAP ; protein S ; non-small cell lung cancer (NSCLC) ; omega-3 fatty acid ; inflammation ; metastasis ; clinical symptoms ; miRNA ; smooth muscle tumor of uncertain malignant potential ; Wnt ; interstitial fluid pressure ; heterogeneity ; hepatocytes ; myometrium ; tumor necrosis factor ? ; tumor ; tumor microenvironment ; extracellular matrix ; TAZ ; carcinogenesis ; cystic formation ; pulmonary fibrosis ; HBV ; cytokine ; genetic instability ; diagnosis ; EMT ; crizotinib ; Hippo pathway ; GPR120 ; marker ; HCV ; non-alcoholic steatohepatitis ; pathology ; common pathways ; apoptosis ; type I collagen ; GPR40 ; acute lung injury ; uterine fibroid ; renal injury ; pathophysiology ; reactive oxygen species ; immunohistochemistry ; SMAD ; butylidenephthalide ; leiomyoma ; cirrhosis ; Erk1/2 ; targeted therapy ; TGF-? ; mechanotransduction ; therapy ; breast cancer ; hepatocellular carcinoma (HCC) ; hepatic stellate cells (HSCs) ; idiopathic pulmonary fibrosis (IPF) ; cancer-associated fibroblasts (CAFs) ; cancer ; signal pathway ; tumor stiffness ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Shiftwork and dietary patterns ; sleep and work ; Sleep and dietary factors ; Diet quality ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; antarctic-derived fungus ; marine drugs analogues ; antitumor ; pallescensone ; Haematococcus pluvialis ; toluquinol ; antiproliferative activity ; astaxanthin ; thymoquinone ; alotamide ; microalgae ; tetrahydropyrans ; isomicrocionin-3 ; hybrid polyketides ; anticonvulsant ; peptide/polyketide molecules ; functional-analogues ; Synechococcus sp. PCC 7942 ; natural compound analogues ; LLC-PK1 cells ; structural modification ; relative structural determination ; benzo[d]thiazol ; Cladosporium sphaerospermum ; hybrid PKS-NRPS ; anticandidal activity ; Octopus minor ; dihydropallescensin 2 ; Candida albicans ; Iso-Seq ; biological activity ; Octominin ; pallescensin 2 ; pallescensin 1 ; stereoselective ; synthetic analogues ; psammaplin A ; cyclogeranylsulfonylbenzene isomers ; synthesis ; smenamides ; MM cell line ; ?-ketoacyl ACP Synthase ; antidepressant ; marine natural products ; marine hydroquinone ; tetramic acid ; asymmetric synthesis ; acid mediated cyclization ; stereoselective synthesis ; GGPPS ; furanosesquiterpenes ; marine natural product ; short chain fatty acids ; antimicrobial peptides ; lipase-mediated resolution ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; polyphenols ; antioxidants ; inflammation ; prevention of non-communicable diseases ; flavonoids ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; PhGs ; bitter orange ; immunomodulator ; A549 cells ; bergapten ; triptolide ; BMP/Smad ; phytochemicals ; antioxidant enzymes ; kumquat ; MTT assay ; HepaRG cells ; human health ; nanoparticles ; dendritic cells ; drug discovery ; biofilm ; catechin ; antitubercular activity ; Panax notoginseng saponins ; animals ; mouse-hair growth ; A? ; curcumin ; WNT/?-catenin ; copaiba ; AD ; Plasmodium parasites ; traditional medicine ; procyanidin A2 ; PET inhibition ; rheumatoid arthritis ; cannabinoid type 1 receptor ; iridoids ; inflammatory bowel disease ; acute liver injury ; human-hair-follicle dermal papilla cells ; Neuroprotective ; dihydromyricetin ; AMPK ; thromboembolism ; ginseng ; drug design and development ; endoplasmic reticulum stress ; mitogen-activated protein kinase ; Nrf2 ; prenylated flavonoids ; inflammation ; preclinical studies ; plants ; dietary supplements ; Glycyrrhiza uralensis ; aspirin ; Tripterygium wilfordii ; P. eryngii ; reperfusion ; ethnopharmacology ; glucans ; innovation ; hpatoprotection ; hinokitiol ; phytocannabinoid ; antistaphylococcal activity ; Shh/Gli ; green tea ; sesquiterpenoids ; adjuvant-induced arthritis ; yuzu ; hepatotoxicity ; p53/Bax ; Keap1 ; nuclear factor-kappaB ; oxidative stress ; pharmacokinetic study ; cinnamamides ; toxicity ; APAP ; Astragali Radix ; computational softwares ; plant natural product ; onion ; anti-malaria activity ; lipogenesis ; bleeding time ; diterpenoids ; Penthorum chinense Pursh ; myocardial hypertrophy ; automation ; adjuvant ; grapefruit ; melanoma cell ; essential oil ; sweet orange ; Amadori rearrangement compounds ; heme oxygenase ; global health ; calorie restriction ; bergamot ; liposomes ; EGCG ; celastrol ; herb–drug interactions ; cannabigerol ; anti-inflammation ; OH· free radical ; molecular targets ; gluconeogenesis ; microbiome ; SIRT1 ; fucoidan ; heart ; PC12 cells ; acetaminophen ; omics ; time-kill assay ; arthritis ; lychee seed ; bioinformatics ; structure–activity relationship ; precision medicine ; orange petitgrain ; immune modulation ; antiproliferation ; flavonoids ; scoulerine ; oleoresin ; triterpenic acids ; Cannabis sativa ; NAFLD ; biological activity ; differentiation ; oxygen consumption rate ; mitochondrial bioenergetics ; neroli ; apoptosis ; targeted delivery ; platelet activation ; protein kinase ; heat-process ; hepatic steatosis ; hyperglycemia ; natural products ; lemon ; genistein ; neuroinflammation ; astragaloside IV ; cytoxicity ; flavonoid ; paracetamol ; medicinal plants ; insulin resistance ; resveratrol ; mandarin ; garlic ; TGF-? ; morin hydrate ; sirtuin 3 ; MMPs ; gomisin N ; lime ; Ziziphus jujuba ; antifungal activity ; ischemia ; migration ; caspases ; small molecules ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; RA1190-1270 ; toxin ; Shiga toxin ; ricin ; Ribosome inactivating protein ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RK1-715 ; dental health services ; oral health care ; parental knowledge ; obvious decay ; young people ; prison ; critical consciousness ; oral health education ; oral health ; attitudes and behaviors ; accessible dental services ; baby oral health ; social and community-based interventions ; undocumented migrants ; homeless persons ; undocumented migrant ; social exclusion ; community health workers ; oral health-related quality of life ; prisons ; inclusion oral health ; homelessness ; delivery of health care ; undocumented immigrants ; pedagogical approaches ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; cancer prevention ; synergistic effects ; Polyphenols ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC321-571 ; microRNAs ; disease-modifying effects ; SH-SY5Y ; inpatient treatment ; sphingolipids ; neurodegeneration ; magnetic resonance spectroscopy ; MO3.13 ; schizophrenia ; epigenetics ; long-chain acylcarnitine ; molecular mimicry ; curli ; multimodal complex treatment ; chlorogenic acid ; glycerophospholipids ; caffeic acid ; lipoproteins ; myenteric plexus ; neurometabolites ; HOG ; immature oligodendrocyte ; autophagy ; oligodendrocyte ; hypochlorite ; alpha-synuclein ; microbiome ; glucocerebrosidase ; Lewy Body Dementia ; brain iron ; mesenchymal stem cells ; fatty acid ?-oxidation ; GABA ; enteric glial cell ; gut-brain axis ; microbiota ; REM sleep behavior disorders ; redox cycling ; magnetic resonance imaging ; differentiation ; ?-synuclein-mediated pathology ; Parkinson disease ; Gaucher’s disease ; metallothionein ; [123I]FP-CIT-SPECT ; dopaminergic neuron ; mature oligodendrocyte ; glycerolipids ; spectroscopy ; neuroinflammation ; exosomes ; immunotherapy ; DNA methylation ; sterol lipids ; nigral cells ; cell line ; cysteinyl-dopamine ; myelin ; parkinsonisms ; multiple sclerosis ; rotenone ; brain ; fatty acyls ; Krabbe’s disease ; neuroprotection ; DAT ; motor dysfunction ; secretome ; multiprofessional therapy ; Parkinson’s disease ; oxidative stress ; alpha-Synuclein ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; clinical application ; differentiation ; adult stem cell ; human disease ; immune response ; induced pluripotent stem cells ; genetic cell stability ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; anticoagulant proteins and peptides ; cardio protective proteins and peptides ; fish collagen ; antifreeze proteins and peptides ; antihypertensive proteins ; anticancer proteins and peptides ; antimicrobial protein and peptides ; antitumor proteins and peptides ; antioxidant proteins and peptides ; macro algae protein ; isolation process ; fish gelatin ; digestive enzymes ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Obesity ; nutrition ; Alzheimer’s disease ; inflammation ; Schizophrenia ; Depression ; Dyslipidaemia ; cancer ; Diabetes ; rheumatoid arthritis ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RS1-441 ; n/a ; medication experience ; medication safety ; collaborative practice ; age disparities ; Comprehensive Medication Management ; pharmacist ; pharmaceutical care ; readmissions ; healthy people 2020 ; multiple chronic conditions ; comparative case study ; billing ; interprofessional care ; clinical pharmacy ; safety ; community pharmacy ; qualitative research ; 21st century history ; medication management ; innovation science ; clinical results ; healthcare access ; documentation ; cost avoidance ; code of ethics ; misuse ; intention ; experiential learning ; opioid use disorder ; pharmacist workforce ; adverse drug events ; cue orientation ; pharmacy intern ; continuity of patient care ; decision-making ; community-based pharmacist practitioners ; service process ; quality assurance ; vaccination ; medication-related problems ; medication therapy management ; chronic kidney disease ; services marketing ; pharmacist roles ; health workers ; disposal ; federally qualified health center ; pharmacy services ; student pharmacist ; pharmacy communication ; interrupted time series analysis ; interprofessional practice and education ; 20th century history ; pharmacist services ; transitions in care ; retail clinics ; pharmacy clinical services ; counseling ; brown bag ; chronic diseases ; observation ; medication therapy problems ; ambulatory care ; mobile health units ; human papilloma virus ; community-based pharmacy ; medication reconciliation ; pharmacy learners ; collaboration ; care plan ; primary care ; interprofessional training ; travel ; theory of planned behavior. ; information sharing ; pharmacy practice ; health care policy ; medication adherence ; ethics ; pharmaceutical intervention ; medication synchronization ; counselling ; comprehensive medication review ; medication use burden ; dispensing ; pharmacy staff ; communication ; mental illness ; pharmacy benefit manager (PBM) ; focus group interviews ; South Asian ; pharmaceutical regulation ; wellness programs ; serviced marketing ; emergency unit ; immunization ; pharmacy ; quality measurement/benchmarking ; advanced practice pharmacist provider ; job satisfaction ; job-related preferences ; naltrexone ; medication discrepancies ; interprofessional ; CMS Star rating ; HPV vaccination ; regulatory ; clinical practice ; community pharmacists ; ethical models ; immunization programs ; health policy ; nurse practitioners ; history of pharmacy ; cystic fibrosis ; focus groups ; community pharmacy practice ; gender disparities ; pharmaceutical care practice ; comprehensive medication management ; value ; design thinking ; grants ; value-added services ; pharmacists ; adherence ; implementation ; opioid ; primary health care ; mental health first aid ; pharmacy practice faculty ; community pharmacy services ; comprehensive medication management services ; pharmacy education ; coordinated care ; management ; mental health care ; competitive advantage ; organizations ; Denmark ; naloxone ; compensation ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; interferon signature score ; interferonopathies ; n/a ; rat model ; pulmonary hypertension ; neurological symptoms ; early-onset sarcoidosis ; sialidosis ; sialidosis I ; children ; mediastinitis ; bilirubin encephalopathy ; Blau syndrome ; myocardial dysfunction ; cardiopulmonary bypass ; neuropathology ; bacteremia ; tissue doppler imaging ; HD-OCT ; biostatistics ; continuous insulin infusion system ; infants ; RNFL ; biomarkers ; diagnosis ; somatosensory evoked potential ; Paediatric sarcoidosis ; diabetic retinopathy ; brain damage ; tonsillectomy ; hybrid closed-loop system ; cytopathology ; neuraminidase ; subcutaneous emphysema ; continuous glucose monitor ; respiratory syncytial virus ; data sharing ; complication ; lysosomal storage disease ; echocardiography ; ONH ; systemic lupus erythematosus ; NT-proBNP ; preterm brain ; head and neck ; inter-laboratory variability ; GSH ; insulin pump ; high-risk sarcoidosis ; type 1 diabetes ; hypoxia-ischemia ; Tei index ; sialidosis II ; mediastinal emphysema ; newborn ; diabetes technology ; diagnostics ; lysosomal exocytosis ; kernicterus ; cerebral palsy ; choroidal thickness ; oxidative stress ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; n/a ; bacteria ; stainless steel ; Escherichia coli ; biofilm formation ; beef ; powdered infant formula ; bile acids ; stx-subtypes ; raw milk ; Shiga toxin-producing Escherichia coli ; Cronobacter sakazakii ; synergism of mild heat and pressure ; raspberry ; blueberry ; biocidal effectiveness ; salmonellosis ; Listeria monocytogenes ; small fruits ; biosensors ; food borne pathogens ; grape ; postharvest diseases ; modified atmosphere packaging ; high hydrostatic pressure ; epithelial barrier ; carvacrol ; dietary bioactive components ; rapid detection ; essential oils ; ozon ; stx-genes ; Cronobacter outbreaks ; habituation ; plant extracts ; Escherichia coli (STEC) ; ozonated water ; disinfectants ; caprylic acid ; foodborne pathogens ; temperature ; natural background microflora ; preventive measures ; carbon dioxide ; nitrogen ; strawberry ; high-pressure pasteurization ; gut microbiota ; food safety ; Shiga toxin-producing Escherichia coli (STEC) ; microfluidic chip ; fungi ; blackberry ; serogroups ; infant care setting ; non-ozonated water ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; receptor activator of nuclear factor ?B ; infliximab ; tripterine ; triptolide ; osteoblast ; tumor necrosis factor-alpha ; synovial cell ; anti-arthritis ; biosimilars ; Epstein-Barr virus ; cytokines ; SOX9 ; parathyroid hormone ; nitric oxide ; rat ; etanercept ; angiogenesis ; glycosylation ; mitogen activated protein kinase ; Th9 lymphocytes ; rheumatoid arthritis ; IL-6 ; clodronate ; bone erosion ; mesenchymal stem cells ; collagen-induced arthritis ; biological ; gene expression ; inflammatory arthritis ; osteoarthritis ; fraxinellone ; nuclear factor kappa B ; messenger RNA ; inflammation ; miRNA ; disease-modifying ; adipokines ; WNT ; glycoprotein 42 ; miR-199a-5p ; proliferation ; next-generation sequencing ; collagen ; osteoarthritis (OA) ; experimental arthritis ; bone morphogenetic protein ; TNF-? ; computational modeling ; basic research ; osteoclast ; therapeutics ; certolizumab pegol ; chondrocytes ; progenitor cells ; adjuvant arthritis ; adalimumab ; triterpenoid ; sclareol ; TNF? ; fibroblast growth factor 2 ; antibodies ; osteoblasts ; molecular pathology ; Th17 ; immunology ; obesity ; visfatin ; articular cartilage ; autoimmune ; biomarkers ; celastrol ; MAPK ; disease pathways ; IL1? ; arthritis ; bioinformatics ; anticitrullinated peptide antibodies ; drug delivery system ; antagonists ; shared epitope ; pathology ; SMA- and MAD-related protein ; small-molecule inhibitor ; transforming growth factor ? ; mice ; golimumab ; spinal fusion ; antirheumatic drug ; early osteoarthritis ; stem cell ; rheumatoid factor ; therapeutic antibody ; bisphosphonate ; osteoclastogenesis ; interleukin ; spondyloarthropathies ; clinical translation ; therapy ; Traditional Chinese medicine ; chemokines ; structure ; cell signaling ; microRNA ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC346-429 ; polymicrogyria ; n/a ; neurodegenerative disease ; next generation sequencing (NGS) ; inborn error of metabolism ; genetic biomarker ; deep learning ; TUBA1A ; Alzheimer’s disease (AD) ; ataxia ; risk prediction ; p.(Arg2His) ; movement science ; tubulin ; R2H ; diagnosis ; machine learning ; metal storage disorders ; amyotrophic lateral sclerosis (ALS) ; glucocerebrosidase ; Parkinsonism ; cerebellar hypoplasia ; Gaucher disease ; disease phenotyping ; tubulinopathy ; Parkinson’s disease (PD) ; dementia ; Parkinson’s disease ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC109-216 ; bacteria ; folding ; co-translational refolding ; RecQ helicase ; regulatory element ; conformational dynamics ; G4Hunter ; NDPK ; fluorescence ; pseudorabies virus ; Epstein-Barr virus (EBV) ; structure-activity relationship ; PhenDC3 ; eukaryotic hosts ; Herpesvirus ; translation suppression ; turn-on ligands ; co-transcriptional folding ; Herpesviridae ; G-quadruplex ; nucleoside diphosphate kinase ; nucleic acids ; nucleic acids conformation ; bioinformatics ; protein–DNA interaction ; aptamers ; deinococcus ; Alphaherpesvirinae ; EBNA1 ; G4 ; virus ; human papillomaviruses ; S. cerevisiae ; genome stability ; G-quadruplexes ; metastable structure ; genome evolution ; pyridostatin ; alphaherpesviruses ; structure ; protozoa ; genome ; G-quadruplex ligand ; NMR ; microbes ; DNA ; protein-mRNA interactions ; G-quadruplex formation ; immediate early promoters ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; enteral nutrition ; enteral feeding methods ; enteral feeds ; evaluation of enteral nutrition ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RS1-441 ; practice ; education ; vaccinations ; vaccines ; malaria prophylaxis ; pharmacy law ; prescribing and education ; pharmacist ; multidisciplinary collaboration ; training ; travel medicine ; malaria ; travel health ; schedules ; community pharmacy ; pharmacists ; health ; ambulatory care ; community ; Switzerland ; Canada ; pharmacy ; South Africa ; Australia ; travel ; vaccination ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; Cervical Cancer ; Viral Pathogenesis ; human papillomavirus ; Viral Carcinogenesis ; Head and Neck Cancer ; HPV ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC955-962 ; n/a ; topical corticosteroids ; mental health ; digital handheld microscope ; skin infections ; sporotrichosis Community dermatology ; mHealth ; animal reservoir ; iatrogenic ; case management ; Wet Dermatoscopy (w-DS) ; Mycobacterium ulcerans ; transmission ; neglected tropical diseases ; review ; Enhanced Dermatoscopy (e-DS) ; outbreak ; long range diagnosis ; teledermatology ; Treponema pallidum ; leprosy ; onchocerciasis ; mass drug administration ; point of care test ; scabies ; Africa ; podoconiosis ; Mite-Gallery Unit (MGU) ; diagnosis ; Amerindian communities ; eumycetoma ; community engagement ; clinical presentation ; integration ; onchocercal skin disease ; mycetoma ; PCR ; mobile phone application ; stigma ; resource-poor setting ; slit skin smears ; morbidity management ; training ; tele-expertise ; ivermectin ; eHealth ; NTDs ; Dry Dermatoscopy (d-DS) ; Amazon lowland ; actinomycetoma ; patient involvement ; tropical skin diseases ; surveillance ; yaws ; skin diseases ; skin NTDs ; lymphedema ; Cushing syndrome ; onchodermatitis ; skin disease ; primary health care ; technology ; skin biopsy ; impetigo ; early diagnosis ; dermatology ; telepathology ; drought ; subcutaneous mycosis ; disease mapping ; emergency state ; Entodermoscopy (EDS) ; leprosy diagnosis ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RM1-950 ; polyphenols ; n/a ; sphericity 4 ; injectable hydrogels ; drug delivery ; silk fibroin ; retinol ; “click” chemistry ; amphiphilic copolymers ; pellet diameter 2 ; lacritin ; caffeic acid ; alkyne–azide reaction ; wound healing ; polymer carriers ; thermogravimetric analysis ; lutein ; nanofibers ; ATRP ; gene delivery ; poly(ionic liquid)s ; allantoin ; micellar carriers ; anticancer activity ; crosslinking ; HUVECs ; natural polymers ; sustained release ; graft copolymers ; crystallinity 3 ; equilibrium swelling ratio ; contact lens ; pinocembrin ; bioconjugation ; accumulative release ; nanoporous silicon ; synthetic polymers ; pellets 1 ; self-assemblies ; stimuli-responsive materials ; protein therapeutics ; sodium alginate ; ?CD polymer ; fast release 5 ; star polymers ; extended release 6 ; controlled release ; conjugates ; polyvinyl alcohol ; graft polymers ; elastin-like polypeptide (ELPs) ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC620-627 ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; functional restoration ; biopsychosocial ; opioid misuse ; chronic low back pain ; interdisciplinary care ; exercise and physical activity ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RA1190-1270 ; toxicity ; intestinal epithelial cells ; n/a ; piglets ; toll-like receptors ; permeability ; aflatoxin M1 ; pig ; N-acetylcysteine ; pigs ; histology ; pre-pubertal gilts ; histopathological lesions ; Mitochondrial apoptosis ; explant technique ; Lactobacillus ; liver ; ergot alkaloids ; digestive tract ; ultrastructure ; hydrogen-rich water ; genotoxicity ; proliferating cell nuclear antigen ; mycotoxin ; feed ; intestinal morphology ; functional oligosaccharides ; Saccharomyces cerevisiae boulardii CNCM I-1079 ; jejunum ; small intestine ; detoxification ; vasoactive intestinal polypeptide ; PCR ; atlantic salmon ; ileum ; microbiota ; sclerotia ; zearalenone ; intestine ; doses ; mycotoxins ; transcriptome ; lipid metabolism ; Zearalenone ; caecal water ; mice ; deoxynivalenol ; aflatoxin B1 ; goblet cells ; inflammation ; intestinal bacterial flora ; SIEC02 cells ; piglet ; colon microbiota ; tight junctions ; tight junction ; suppressor of cytokine signaling ; ochratoxin A ; Claviceps ; T-2 toxin ; MiSeq 16S rDNA sequencing ; lactulose ; Clostridium sp. WJ06 ; swine ; intestinal microbiota ; fumonisin ; response ; contaminated feed ; Fusarium mycotoxins ; microbial diversity ; enteric nervous system ; large intestine ; ultrastructural changes ; oxidative stress ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; RC321-571 ; norepinephrine ; medial prefrontal cortex ; fear extinction ; emotion regulation ; emotion processing ; connectivity ; anticipatory arousal ; Pavlovian ; triadic neural systems model ; prelimbic ; development ; positive and negative ; rat ; Williams Syndrome ; psychological treatment ; glia density ; anxiety ; fMRI ; area 25 ; anhedonia ; adolescence ; adolescent ; autonomic ; amygdala ; neuron density ; neural ; prefrontal cortex ; reliability ; functional magnetic resonance imaging (fMRI) ; networks ; cAMP ; cognitive control ; extinction ; infralimbic ; NMDA ; reward ; calcium ; stress adolescence ; BDNF ; machine learning ; negative affect ; hierarchical control ; emotion ; occasion setting ; serotonin transporter ; ventromedial prefrontal cortex ; psychophysiology ; depression ; aging ; dopamine ; age ; bic Book Industry Communication::M Medicine

Keywords: R5-920 ; QH301-705.5 ; RM1-950 ; QD415-436 ; Metal-based drugs ; Platinum complexes anticancer agents ; Non-platinum metal complexes anticancer agents ; Metal complexes interactions with nucleic acids ; Inorganic Biochemistry ; Metal complexes interactions with DNA